Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
12 September 2024
| Name: | OSPREY MEDICAL INC (OSP) |
| ISIN: | AU000000OSP4 |
| Date of Listing: | 02 May 2012 |
| Date of Delisting: | 29 August 2022 |
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 29 August 2022.Legal Status:
ACN: 152 854 923ABN: 97 152 854 923
Registration Date: 24 August 2011
Deregistration Date: 17 January 2023
Capital Gains Tax (CGT) Status:
This entity was deregistered on 17 January 2023. Deregistration is a Capital Gains Tax Event. In our opinion you are entitled to crystallise any capital loss in the tax year that deregistration occurs providing you have not previously done so. If you did not crystallise your loss in the tax year the entity was deregistered, you may seek to re-open that year’s assessment but anyway should seek professional advice as to how best to proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
REGISTRY:
Link Market Services Melbourne
Tower 4, 727 Collins Street Docklands VIC 3008
Tel : +61 3 9615 9800 or 61 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail
company is deregistered today | 17/01/2023 |
Strike-Off Action In Progress | 30/10/2022 |
delisted following failure to pay the annual ASX listing fees per Listing Rule 17.15 | 29/08/2022 |
we understand the company failed to pay to ASX Limited the annual listing fees for the year ending 30 June 2023 | 29/08/2022 |
Under Listing Rule 17.6, an entity (if not already suspended) that had not paid its annual listing fees by close of business on Friday, 19 August 2022 would have its securities suspended from Official Quotation before the commencement of trading on Monday, 22 August 2022. The following entity has failed to pay to ASX Limited the annual listing fees for the year ending 30 June 2023, and each entity's securities are already suspended from quotation. Under Listing Rule 17.15, any entity that has not paid its annual listing fees as required by Listing Rule 16.5 by 5.00 pm AEST on Friday, 26 August 2022 will be removed from the Official List with effect from the close of trading on Friday, 26 August 2022. | 22/08/2022 |
The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report. | 29/07/2022 |
The Company is working with creditors and other stakeholders to reduce the Company's debt and gain access to new sources of liquidity. Cash from ongoing operations is expected to provide sufficient liquidity to support Osprey's continuing business operations and minimise disruption to customers until completion of the restructure of Osprey's business in CY 2023. The Company expects that its shares will remain suspended from trading until at least completion of the business restructure. | 01/06/2022 |
The company has postponed the AGM scheduled for 2 June 2022 until further notice. | 26/05/2022 |
The company is continuing its suspension from trading in order to provide Osprey with additional time to complete its consideration of the options available to it and to provide the market with an accurate update on next steps. The suspension will continue for a period of up to 16 trading days; and the suspension will end upon the release of an announcement by Osprey in connection with its review of options. | 10/05/2022 |
The company is reducing its workforce across all areas effective this Friday (US time). The company continues to assess next steps and expects to update the market shortly on further developments. | 06/05/2022 |
The securities of Osprey Medical Inc. will be suspended from quotation immediately under Listing Rule 17.2, at the request of OSP, pending the release of an announcement regarding its strategic and funding options. | 03/05/2022 |
The securities of Osprey Medical Inc (the "Company") will be reinstated to quotation immediately, following the release of an announcement by the Company. Security Code: OSP | 23/03/2015 |
The securities of Osprey Medical Inc (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the company. Security Code: OSP | 19/03/2015 |
listed entity carried for record purposes only | 02/05/2012 |
company is deregistered today | 17/01/2023 |
Strike-Off Action In Progress | 30/10/2022 |
delisted following failure to pay the annual ASX listing fees per Listing Rule 17.15 | 29/08/2022 |
we understand the company failed to pay to ASX Limited the annual listing fees for the year ending 30 June 2023 | 29/08/2022 |
Under Listing Rule 17.6, an entity (if not already suspended) that had not paid its annual listing fees by close of business on Friday, 19 August 2022 would have its securities suspended from Official Quotation before the commencement of trading on Monday, 22 August 2022. The following entity has failed to pay to ASX Limited the annual listing fees for the year ending 30 June 2023, and each entity's securities are already suspended from quotation. Under Listing Rule 17.15, any entity that has not paid its annual listing fees as required by Listing Rule 16.5 by 5.00 pm AEST on Friday, 26 August 2022 will be removed from the Official List with effect from the close of trading on Friday, 26 August 2022. | 22/08/2022 |
The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report. | 29/07/2022 |
The Company is working with creditors and other stakeholders to reduce the Company's debt and gain access to new sources of liquidity. Cash from ongoing operations is expected to provide sufficient liquidity to support Osprey's continuing business operations and minimise disruption to customers until completion of the restructure of Osprey's business in CY 2023. The Company expects that its shares will remain suspended from trading until at least completion of the business restructure. | 01/06/2022 |
The company has postponed the AGM scheduled for 2 June 2022 until further notice. | 26/05/2022 |
The company is continuing its suspension from trading in order to provide Osprey with additional time to complete its consideration of the options available to it and to provide the market with an accurate update on next steps. The suspension will continue for a period of up to 16 trading days; and the suspension will end upon the release of an announcement by Osprey in connection with its review of options. | 10/05/2022 |
The company is reducing its workforce across all areas effective this Friday (US time). The company continues to assess next steps and expects to update the market shortly on further developments. | 06/05/2022 |
The securities of Osprey Medical Inc. will be suspended from quotation immediately under Listing Rule 17.2, at the request of OSP, pending the release of an announcement regarding its strategic and funding options. | 03/05/2022 |
The securities of Osprey Medical Inc (the "Company") will be reinstated to quotation immediately, following the release of an announcement by the Company. Security Code: OSP | 23/03/2015 |
The securities of Osprey Medical Inc (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the company. Security Code: OSP | 19/03/2015 |
listed entity carried for record purposes only | 02/05/2012 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 04/03/2019 | Neville Mitchell | 185,809 | $0.110 | $20,362 | |
| 06/06/2018 | Neville Mitchell | 250,000 | $0.150 | $37,500 | |
| 15/05/2018 | Neville Mitchell | 250,000 | $0.190 | $47,500 | |
| 17/05/2016 | Neville Mitchell | On market CDI | 100,000 | $0.252 | $25,180 |
| 16/05/2014 | Neville Mitchell | On market CDI | 50,000 | $0.541 | $27,061 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| John Erb | Non Exec Chairman | 02/05/2012 |
| Mike McCormick | President, CEO | 02/05/2012 |
| Chris Nave | Non Exec Director | 02/05/2012 |
| Martin Emerson | Director | 12/08/2021 |
| Steven Brandt | Director | 01/07/2021 |
| Brendan Case | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Neville Mitchell | Director | 03/07/2012 | 26/05/2022 |
| Sandra Lesenfants | Non Exec Director | 20/06/2017 | 25/05/2022 |
| Andy Jane | Director | 13/11/2012 | 18/08/2020 |
| Mark Harvey | Non Exec Director | 02/05/2012 | 13/11/2012 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
